Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more
Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more
How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more